Die Therapie des primär oligometastasierten Prostatakarzinoms
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
https://link.springer.com/content/pdf/10.1007/s00120-021-01643-0.pdf
Reference28 articles.
1. Ali A, Hoyle A, Haran ÁM et al (2021) Association of bone metastatic burden with survival benefit from prostate radiotherapy in patients with newly diagnosed metastatic prostate cancer. A secondary analysis of a randomized clinical trial. JAMA Oncol 7(4):555–563
2. de Bleser E, Jereczek-Fossa BA, Pasquier D et al (2019) Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer. A multi-institutional analysis comparing the outcome and toxicity of Stereotactic body radiotherapy and elective nodal radiotherapy. Eur Urol 76(6):732–739
3. Boevé LMS, Hulshof MCCM, Vis AN et al (2019) Effect on survival of androgen deprivation therapy alone compared to androgen deprivation therapy combined with concurrent radiation therapy to the prostate in patients with primary Bone metastatic prostate cancer in a prospective Randomised clinical trial. Data from the HORRAD trial. Eur Urol 75(3):410–418
4. Burdett S, Boevé LM, Ingleby FC et al (2019) Prostate radiotherapy for metastatic hormone-sensitive prostate cancer. A STOPCAP systematic review and meta-analysis. Eur Urol 76(1):115–124
5. Chi KN, Agarwal N, Bjartell A et al (2019) Apalutamide for metastatic, castration-sensitive prostate cancer. N Engl J Med 381(1):13–24
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Systemtherapie des metastasierten Prostatakarzinoms;TumorDiagnostik & Therapie;2022-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3